These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 37543795)

  • 1. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma.
    Zou J; Chu S; Bao Q; Zhang Y
    Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-derived molecular subtype and gene signature characterize prognoses and therapeutic responses in head and neck squamous cell carcinoma.
    Zou J; Chu S; Zhou H; Zhang Y
    Medicine (Baltimore); 2024 Feb; 103(6):e37233. PubMed ID: 38335389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma.
    Mu R; Shen Y; Guo C; Zhang X; Yang H; Yang H
    Mediators Inflamm; 2023; 2023():8533476. PubMed ID: 39282247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy.
    Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y
    Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
    Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
    BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes.
    Zhang A; Jin Y; Zou X; Zhang S
    Medicine (Baltimore); 2023 Jul; 102(28):e34275. PubMed ID: 37443469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtype identification and prognosis stratification based on golgi apparatus-related genes in head and neck squamous cell carcinoma.
    Zhang A; He X; Zhang C; Tang X
    BMC Med Genomics; 2024 Feb; 17(1):53. PubMed ID: 38365684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma.
    Huang J; Xu Z; Wang Z; Zhou C; Shen Y
    Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC.
    Chi H; Peng G; Song G; Zhang J; Xie X; Yang J; Xu J; Zhang J; Xu K; Wu Q; Yang G
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):130. PubMed ID: 38538268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
    Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
    Front Immunol; 2022; 13():961695. PubMed ID: 36389709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma.
    Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y
    Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination-Related Gene Signature, Nomogram and Immune Features for Prognostic Prediction in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang H; Zhou L; Shi M; Yu J; Xie Y; Sun Y
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC.
    Chi H; Xie X; Yan Y; Peng G; Strohmer DF; Lai G; Zhao S; Xia Z; Tian G
    Front Immunol; 2022; 13():1018685. PubMed ID: 36263048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
    Yang F; Zhou LQ; Yang HW; Wang YJ
    Front Genet; 2022; 13():927614. PubMed ID: 36092911
    [No Abstract]   [Full Text] [Related]  

  • 19. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation.
    Liu Y; Wu Z; Fu Z; Han Y; Wang J; Zhang Y; Liang B; Tao Y; Zhang Y; Shen C; Xu Y; Yin S; Chen B; Liu Y; Pan H; Liang Z; Wu K
    Front Immunol; 2023; 14():1190678. PubMed ID: 37691922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
    Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.